Elevance Health, Inc. (LON:0HG8)

Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of GBP 56.01 billion. The enterprise value is 72.55 billion.

Market Cap	56.01B
Enterprise Value	72.55B

Important Dates

The last earnings date was Wednesday, January 28, 2026.

Earnings Date	Jan 28, 2026
Ex-Dividend Date	Dec 5, 2025

Share Statistics

Current Share Class	222.24M
Shares Outstanding	n/a
Shares Change (YoY)	-3.56%
Shares Change (QoQ)	-0.85%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	91.27%
Float	221.75M

Valuation Ratios

The trailing PE ratio is 13.31 and the forward PE ratio is 13.41.

PE Ratio	13.31
Forward PE	13.41
PS Ratio	0.38
PB Ratio	1.71
P/TBV Ratio	17.38
P/FCF Ratio	23.75
P/OCF Ratio	17.57
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.07, with an EV/FCF ratio of 30.77.

EV / Earnings	17.25
EV / Sales	0.50
EV / EBITDA	10.07
EV / EBIT	11.94
EV / FCF	30.77

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.73.

Current Ratio	1.54
Quick Ratio	1.41
Debt / Equity	0.73
Debt / EBITDA	3.24
Debt / FCF	10.10
Interest Coverage	5.94

Financial Efficiency

Return on equity (ROE) is 13.25% and return on invested capital (ROIC) is 9.24%.

Return on Equity (ROE)	13.25%
Return on Assets (ROA)	4.37%
Return on Invested Capital (ROIC)	9.24%
Return on Capital Employed (ROCE)	10.36%
Weighted Average Cost of Capital (WACC)	6.08%
Revenue Per Employee	1.42M
Profits Per Employee	40,373
Employee Count	104,200
Asset Turnover	1.67
Inventory Turnover	n/a

Taxes

In the past 12 months, Elevance Health has paid 779.41 million in taxes.

Income Tax	779.41M
Effective Tax Rate	15.63%

Stock Price Statistics

The stock price has decreased by -13.85% in the last 52 weeks. The beta is 0.52, so Elevance Health's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-13.85%
50-Day Moving Average	349.02
200-Day Moving Average	347.86
Relative Strength Index (RSI)	43.02
Average Volume (20 Days)	1,038

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.29

Income Statement

In the last 12 months, Elevance Health had revenue of GBP 147.95 billion and earned 4.21 billion in profits. Earnings per share was 18.73.

Revenue	147.95B
Gross Profit	37.82B
Operating Income	6.19B
Pretax Income	4.99B
Net Income	4.21B
EBITDA	7.34B
EBIT	6.19B
Earnings Per Share (EPS)	18.73

Balance Sheet

The company has 26.83 billion in cash and 23.81 billion in debt, with a net cash position of -16.76 billion.

Cash & Cash Equivalents	26.83B
Total Debt	23.81B
Net Cash	-16.76B
Net Cash Per Share	n/a
Equity (Book Value)	32.71B
Book Value Per Share	147.00
Working Capital	16.32B

Cash Flow

In the last 12 months, operating cash flow was 3.19 billion and capital expenditures -829.19 million, giving a free cash flow of 2.36 billion.

Operating Cash Flow	3.19B
Capital Expenditures	-829.19M
Free Cash Flow	2.36B
FCF Per Share	n/a

Margins

Gross margin is 25.56%, with operating and profit margins of 4.19% and 2.84%.

Gross Margin	25.56%
Operating Margin	4.19%
Pretax Margin	3.37%
Profit Margin	2.84%
EBITDA Margin	4.96%
EBIT Margin	4.19%
FCF Margin	1.59%

Dividends & Yields

This stock pays an annual dividend of 5.14, which amounts to a dividend yield of 1.49%.

Dividend Per Share	5.14
Dividend Yield	1.49%
Dividend Growth (YoY)	1.12%
Years of Dividend Growth	8
Payout Ratio	27.00%
Buyback Yield	3.56%
Shareholder Yield	5.05%
Earnings Yield	7.51%
FCF Yield	4.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5